| 
			
			 Volunteers in the study underwent one of six minor surgeries: 
			laparoscopic gallbladder removal, laparoscopic repair of a groin 
			hernia, removal of the thyroid or parathyroid gland, robot-assisted 
			removal of the prostate, endoscopic sinus surgery, and a type of 
			weight-loss surgery called laparoscopic sleeve gastrectomy. 
 Before the surgery, the 190 volunteers received counseling on pain 
			management and were advised to take a non-opioid pain reliever every 
			three hours, alternating between 600 milligrams of ibuprofen and 650 
			mg of acetaminophen.
 
 Researchers also gave patients a small prescription of 5-mg pills 
			containing the opioid oxycodone, counseling them to take the 
			narcotic only if their pain was unmanageable.
 
 When researchers contacted the patients one to three months after 
			the surgeries, they learned that 52% hadn't used any opioids at all.
 
			
			 
			
 Among those who did use opioids, 98% used no more than 10 pills and 
			almost all agreed that their pain was manageable under this regimen, 
			the researchers report in Journal of the American College of 
			Surgeons.
 
 "Over the years, surgeons often prescribed 20 to 40 oxycodone 
			tablets after many procedures. This study and others like it suggest 
			that those quantities were not necessary in many cases," said Dr. 
			Kevin Hill of the Harvard Medical School in Boston, who was not 
			involved in the study.
 
 "The efficacy of this protocol is more about expectation setting, 
			education and using non-opioid pain medications which are very 
			powerful," coauthor Dr. Chad Brummett of the University of Michigan 
			Medical School in Ann Arbor told Reuters Health by phone.
 
 "The fundamental concept is that we as surgeons and dentists are 
			gatekeepers to opioid exposure," said coauthor Dr. Michael Englesbe, 
			also of the University of Michigan. He noted that most heroin users 
			and people at risk of overdose got their first exposure to opioids 
			from a medical care provider.
 
			
            [to top of second column] | 
            
			 
			Up to 10% of patients who take opioids for the first time after an 
			operation develop long-term dependence, and this risk of dependence 
			has been found to be associated with the size of the initial 
			prescription, the researchers wrote. 
			Prior studies have also found that patients tend to have about 19 
			leftover pills after their recovery. In the current study, half the 
			patients had no more than two pills left over from the small supply 
			they had been given.
 Excessive prescribing of opioids increases the risk of prolonged use 
			and results in leftover pills getting diverted and being abused by 
			others, especially adolescents.
 
 In 2017 in the U.S., an estimated 11.4 million people aged 12 or 
			older had misused opioids in the past year, according to data from 
			the National Survey on Drug Use and Health.
 
			The study results prove that many surgery patients don't need 
			opioids to manage pain and that use of these painkillers needs to be 
			de-emphasized where possible, said Beth Darnall, a pain researcher 
			at the Stanford University School of Medicine in California, who 
			also was not involved in the study.
 "That said, some patients absolutely need opioids, and we need to be 
			mindful of this variability," she added.
 
 Brummett and Englesbe and their colleagues acknowledge in their 
			report that this approach "might not be appropriate for more complex 
			procedures." Going forward, they hope to learn more about its 
			feasibility across multiple surgical procedures and across a diverse 
			patient population.
 
 "It will be important to understand the patient characteristics that 
			favor the use of this pathway," they conclude.
 
 SOURCE: https://bit.ly/2IfWeid Journal of the American College of 
			Surgeons, online May 31, 2019.
 
			[© 2019 Thomson Reuters. All rights 
				reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content. |